There were 1,372 press releases posted in the last 24 hours and 248,100 in the last 365 days.

Immunofluorescence Assay Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Immunofluorescence Assay Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON , UK, September 19, 2022 /EINPresswire.com/ -- According to ‘Immunofluorescence Assay Global Market Report 2022’ published by The Business Research Company, the immunofluorescence assay market size is expected to grow from $2.71 billion in 2021 to $2.90 billion in 2022 at a compound annual growth rate (CAGR) of 6.93%. As per TBRC’s immunofluorescence assay market research the market size is expected to grow to $3.68 billion in 2026 at a compound annual growth rate (CAGR) of 6.14%. The increasing prevalence of chronic diseases is significantly driving the growth of the immunofluorescence assay market.

Want to learn more on the immunofluorescence assay market growth? Request for a Sample now: https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp

The immunofluorescence assay market consists of sales of immunofluorescence assays and related products by entities (organizations, sole traders, partnerships) that refer to equipment and consumables that operate on a technique that allows the visualization of specific proteins and antigens in infected cells based on their ability to react with specific antibodies by binding a particular antibody chemically conjugated with a fluorescent dye. It is a technique used in the laboratory to diagnose diseases of the skin, kidney, heart, cilia, and other organ systems.

Global Immunofluorescence Assay Market Trends Technological advancement is a key trend gaining popularity in the immunofluorescence assay market. The companies operating in immunofluorescence assay are focusing on developing technologically innovative products to meet specific technical demands for the diagnosis of new viruses such as COVID-19 and strengthen their market position.

Global Immunofluorescence Assay Market Segments The global immunofluorescence assay market is segmented: By Type: Direct Immunofluorescence, Indirect Immunofluorescence By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Others By End User: Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers By Geography: The global immunofluorescence assay market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.

Read more on the global immunofluorescence assay market report at: https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Immunofluorescence Assay Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides immunofluorescence assay global market overviews, immunofluorescence assay global market analysis and forecasts market size and growth for the global immunofluorescence assay market, immunofluorescence assay market share, immunofluorescence assay global market segments and geographies, immunofluorescence assay global market players, immunofluorescence assay global market leading competitor revenues, profiles and market shares. The immunofluorescence assay industry report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.

TBRC’s Immunofluorescence Assay Global Market Report 2022 includes information on the following:

Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: Thermo Fisher Scientific, Inc., Abcam plc, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc., Zyagen, J. Mitra & Co. Pvt. Ltd., AESKU GROUP GmbH, Vector Laboratories, Inc., EpiGentek Group, and Elabscience, Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Looking for something else? Here is a list of similar reports by The Business Research Company:

Cell Based Assays Global Market Report 2022 https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Multiplex Assays Global Market Report 2022 https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Lateral Flow Assays Global Market Report 2022 https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

About The Business Research Company

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Contact Information: The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info

Check out our: TBRC Blog: http://blog.tbrc.info/ LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham The Business Research Company + +44 20 7193 0708 info@tbrc.info Visit us on social media: Facebook Twitter LinkedIn

Market Research Products, Services, Solutions For Your Business - TBRC

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.